Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis
Sponsor: Xijing Hospital
Summary
Although the incidence of inflammatory bowel disease is stable in North American and European countries, the incidence of inflammatory bowel disease is increasing in newly industrialized countries, especially in China. The treatment drugs for ulcerative colitis include 5-aminosalicylic acid (5-ASA), glucocorticoids, immunosuppressants, and biological agents. The aim of this clinical trial is to evaluate the long-term safety and efficacy of sacral nerve stimulation in patients with ulcerative colitis
Official title: An Open-label Clinical Trial to Evaluate the Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2025-08-02
Completion Date
2032-12-01
Last Updated
2025-08-11
Healthy Volunteers
No
Conditions
Interventions
Sacral nerve stimulation
Device: G132 system, Beijing PINS Medical Co., China Neuromodulation was performed according to the usual protocol
Locations (1)
Xijing Hospital
Xi'an, Shaanxi, China